Can Red Blood Cells Help Control Blood Sugar?
Yes, at least in mice. Researchers led by Dr. Isha Jain found that red blood cells act as “glucose sponges” when oxygen levels drop, soaking up large amounts of sugar from the blood. In low oxygen, the mice made far more red blood cells, and those cells took up about 3 times more glucose. A drug that mimics this effect completely abolished high blood sugar in mice fed a high-fat diet.
People who live at higher altitudes tend to develop diabetes less often than those at sea level. Scientists have noticed this pattern for years, but nobody could fully explain why. This new study, published in Cell Metabolism in 2026, finally cracks the code. It turns out your red blood cells have a hidden talent that switches on when oxygen gets thin.
How Red Blood Cells Become Glucose Sponges
When you go to a high altitude, there is less oxygen in the air. Your body has to adapt. The research team, led by Dr. Isha Jain, discovered that red blood cells respond to low oxygen by ramping up how much glucose they pull from the bloodstream. They use that extra sugar to produce a molecule that helps release oxygen to tissues, which is critical when the air is thin.
Think of it like a sponge dropped into a puddle. Under normal conditions, red blood cells sip a modest amount of glucose. But when oxygen drops, they start absorbing it aggressively. In low oxygen, the total mass of red blood cells in the mice nearly doubled, and the researchers concluded that red blood cells were the main destination for the extra glucose being cleared.
What makes this finding even more striking is how the researchers stumbled upon it. They tracked glucose through the bodies of mice using imaging techniques. When they exposed the mice to low oxygen, blood sugar fell and the mice cleared a glucose dose much faster. But when they checked the major internal organs, about 70% of the extra glucose uptake could not be accounted for. The answer was hiding in the red blood cells all along.
Dr. Kumar’s Take
I find this study genuinely exciting for a few reasons. First, it solves a long-standing mystery about altitude and diabetes that has puzzled researchers for decades. Second, it reveals an entirely new way the body handles blood sugar, one that nobody was targeting with current diabetes treatments. The idea of a drug that tricks red blood cells into absorbing more glucose is a creative approach that could complement existing therapies. That said, this work is still in the mouse stage, and there could be side effects from reducing oxygen delivery to tissues. I will be watching closely as this moves toward clinical trials.
A Drug That Mimics Thin Air
The most promising part of this research is the drug called HypoxyStat, recently developed in Dr. Jain’s lab. This drug, given to the mice by mouth through a feeding tube, works by making hemoglobin, the oxygen-carrying protein in red blood cells, grip onto oxygen more tightly. This limits how much oxygen reaches the body’s tissues, essentially mimicking what happens at high altitude.
When researchers gave HypoxyStat to mice fed a high-fat diet, the results were remarkable. The drug completely abolished their diet-induced high blood sugar and fully normalized their glucose tolerance. Separately, low oxygen itself reversed high blood sugar in a mouse model of type 1 diabetes. The benefits of low-oxygen exposure faded after the mice returned to normal oxygen. Fasting blood sugar went back to normal levels within 14 days, and glucose tolerance took more than a month to fully return to normal.
What This Means for Diabetes Treatment
Current diabetes drugs work by targeting the pancreas, the liver, or the gut. This study opens up a completely different approach: targeting red blood cells. Since red blood cells make up a huge portion of the cells in your body, turning them into glucose absorbers could have a powerful effect on blood sugar levels.
This does not mean you should move to the mountains to manage your diabetes. But it does suggest that future medications could tap into this natural altitude response without requiring you to leave sea level.
Practical Takeaways
- Talk to your doctor about current evidence-based diabetes treatments, as HypoxyStat is not yet available for human use and remains in the early research stage.
- Keep an eye on this line of research if you have type 2 diabetes, because red blood cell-targeted therapies represent a completely new class of potential treatments.
- Do not attempt to simulate low-oxygen conditions on your own, as reducing oxygen delivery can be dangerous without medical supervision.
- Continue following proven strategies for blood sugar management, including regular exercise, balanced nutrition, and any medications prescribed by your doctor.
Related Studies and Research
- Exercise Intolerance and Impaired Oxygen Extraction in Long COVID explores how oxygen delivery problems affect metabolism and exercise capacity.
- Does High LDL-C Help Elderly People Live Longer? A Review of 19 Studies examines another surprising finding about how common blood markers relate to health outcomes.
- Omega-3 Fatty Acids and Type 2 Diabetes Risk: What the Latest Research Reveals covers another promising approach to reducing diabetes risk through a different mechanism.
FAQs
Why do people at high altitudes have lower diabetes rates?
The air at high altitude contains less oxygen, which triggers red blood cells to absorb more glucose from the bloodstream. This natural response effectively lowers blood sugar levels over time. Population studies have consistently shown that communities living at higher elevations develop type 2 diabetes less frequently than those at sea level. This new research in mice offers the biological explanation for that pattern, pointing to red blood cells as the key link between altitude and improved glucose control.
What is HypoxyStat and when will it be available?
HypoxyStat is an experimental drug recently developed in Dr. Isha Jain’s lab. It works by making hemoglobin hold onto oxygen more tightly, which mimics what happens to your body at high altitude. In mice fed a high-fat diet, it completely abolished diet-induced high blood sugar. This study tested it only in mice, and it would need to prove safe and effective in people before it could become available to patients.
Could this discovery change how we treat type 2 diabetes?
This research opens up an entirely new target for diabetes treatment that no current medication addresses. Today’s diabetes drugs focus on the pancreas, liver, or gut to control blood sugar. Targeting red blood cells instead could offer a complementary approach, especially for patients who do not respond well to existing therapies. In this study, the mice received HypoxyStat every day, and the benefits of low-oxygen exposure faded within about a month after it stopped. If human trials confirm these results, red blood cell-targeted therapies could become an important addition to the diabetes treatment toolbox.
Bottom Line
In mice, researchers found that red blood cells act as powerful glucose sponges when oxygen levels drop, finally explaining why people at high altitudes have lower diabetes rates. Their experimental drug HypoxyStat, which mimics this altitude effect, completely abolished diet-induced high blood sugar in mice. While human trials are still needed, this finding reveals a completely new approach to treating type 2 diabetes by targeting the most abundant cells in your blood.
